151 related articles for article (PubMed ID: 26277697)
1. Dexamethasone-suppressed corticotropin-releasing hormone stimulation test in morbid obese adults.
Saiegh L; Keren D; Rainis T; Sheikh-Ahmad M; Reut M; Nakhleh A; Wirsansky I; Chen-Konak L; Schiff E; Shechner C
Obes Res Clin Pract; 2016; 10(3):275-82. PubMed ID: 26277697
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
3. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
J Clin Endocrinol Metab; 1998 Feb; 83(2):348-52. PubMed ID: 9467539
[TBL] [Abstract][Full Text] [Related]
4. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
5. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
[TBL] [Abstract][Full Text] [Related]
7. The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome.
Reimondo G; Bovio S; Allasino B; De Francia S; Zaggia B; Micossi I; Termine A; De Martino F; Paccotti P; Di Carlo F; Angeli A; Terzolo M
Eur J Endocrinol; 2008 Nov; 159(5):569-76. PubMed ID: 18713844
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism.
Erickson D; Natt N; Nippoldt T; Young WF; Carpenter PC; Petterson T; Christianson T
J Clin Endocrinol Metab; 2007 Aug; 92(8):2972-6. PubMed ID: 17488798
[TBL] [Abstract][Full Text] [Related]
9. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
Duclos M; Corcuff JB; Roger P; Tabarin A
Clin Endocrinol (Oxf); 1999 Dec; 51(6):725-31. PubMed ID: 10619977
[TBL] [Abstract][Full Text] [Related]
10. Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome.
Batista DL; Courcoutsakis N; Riar J; Keil MF; Stratakis CA
J Clin Endocrinol Metab; 2008 Nov; 93(11):4323-30. PubMed ID: 18728165
[TBL] [Abstract][Full Text] [Related]
11. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.
Valassi E; Swearingen B; Lee H; Nachtigall LB; Donoho DA; Klibanski A; Biller BM
J Clin Endocrinol Metab; 2009 Dec; 94(12):4851-9. PubMed ID: 19850679
[TBL] [Abstract][Full Text] [Related]
12. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
13. A suppressive effect of dexamethasone (DEX) on adrenocorticotropin (ACTH) response to vasoactive intestinal peptide (VIP) in Cushing's disease: a parallel modulation by DEX of ACTH responses to VIP and corticotropin-releasing hormone.
Watanobe H; Tamura T
Neuropeptides; 1997 Feb; 31(1):35-40. PubMed ID: 9574835
[TBL] [Abstract][Full Text] [Related]
14. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
15. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
[TBL] [Abstract][Full Text] [Related]
16. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
19. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
20. The addition of corticotropin-releasing hormone to 2-day low dose dexamethasone suppression test provides additional case detection.
Wehbeh L; Alwahab UA; Mikhael A; Dobri G; Yogi-Morren D; Kennedy L; Hamrahian AH
Endocrine; 2023 May; 80(2):425-432. PubMed ID: 36917416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
